Einav N. Yam
Tel Litwinsky, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: April 24, 2026
InSituPREP enables 3D single-cell mapping of interaction-associated gene programs in the breast cancer tumor microenvironment.
Journal: Nucleic acids research
Published: November 23, 2025
M196R-TNFR2 and membrane TNFα down-regulate soluble TNFα-induced pro-metastatic functions in triple-negative breast cancer cells.
Journal: Cancer cell international
Published: September 10, 2025
Identifying patients most likely to benefit from routine post-operative mammogram after breast-conserving surgery.
Journal: Breast cancer research and treatment
Published: June 26, 2025
First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer.
Journal: The New England journal of medicine
Published: June 02, 2025
ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1-mutated, metastatic breast cancer.
Journal: Future oncology (London, England)
Published: April 13, 2025
Limited Axillary Dissection for Substantial Breast Cancer Axillary Tumor Burden.
Journal: The Journal of surgical research
Published: April 11, 2025
Integrated spatial proteomic analysis of breast cancer heterogeneity unravels cancer cell phenotypic plasticity.
Journal: Nature communications
Published: December 31, 2024
Deep phenotyping of health-disease continuum in the Human Phenotype Project.
Journal: Nature medicine
Published: August 01, 2024
ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.
Journal: Breast cancer research and treatment
Published: June 11, 2024
Last Updated: 09/26/2026